In The News View All

  • Ramipril in High Risk Patients with COVID-19
    AbstractBackgroundThe coronavirus disease 2019 (COVID-19) is caused by SARS-CoV2 that interfaces with the renin-angiotensin-aldosterone system (RAAS) through angiotensin-converting enzyme 2 (ACE-2). This interaction has been proposed as a potential risk factor in patients treated with RAAS-inhibitors.ObjectivesTo analyze if RAAS-inhibitors modify ...
    Published on 2020-05-26

Authors